A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans
- PMID: 29199844
- PMCID: PMC6148355
- DOI: 10.1037/adb0000326
A scoping review and meta-analysis of psychosocial and pharmacological treatments for cannabis and tobacco use among African Americans
Abstract
The rates of co-occurring cannabis and tobacco use are higher among African Americans relative to other racial/ethnic groups. One plausible approach to treating co-use among African Americans is to examine the effectiveness of treatments for the sole use of cannabis and tobacco to identify effective approaches that might be combined to treat the dual use of these substances. The current meta-analysis sought to include studies that reported cannabis and/or tobacco use outcomes from randomized clinical trials (RCTs) with 100% African American samples. A total of 843 articles were considered for inclusion, 29 were reviewed by independent qualitative coders, and 22 were included in the review. There were no articles on cannabis use treatment with a 100% African American sample, resulting in a need to lower the threshold (60%) and conduct a scoping review of cannabis studies. Preliminary evidence from a small number of studies (k = 7) supports the use of Motivational Interviewing and Cognitive-Behavioral Therapy to treat cannabis use among African Americans, but not Contingency Management. Results from a meta-analysis of 15 tobacco studies found higher rates of smoking abstinence in the treatment condition relative to control conditions overall and across short and long-term follow-up periods. Significant differences in smoking abstinence were also found when examining the effects of pharmacological treatments relative to their control conditions. The clinical and research implications of these findings for future psychosocial and pharmacological trials for cannabis and tobacco use and co-use among African Americans are described. (PsycINFO Database Record
(c) 2017 APA, all rights reserved).
Figures
Similar articles
-
[Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects].Therapie. 2016 Jun;71(3):315-22. doi: 10.1016/j.therap.2016.02.027. Epub 2016 Feb 16. Therapie. 2016. PMID: 27235655 Review. French.
-
A systematic review and Bayesian meta-analysis of interventions which target or assess co-use of tobacco and cannabis in single- or multi-substance interventions.Addiction. 2020 Oct;115(10):1800-1814. doi: 10.1111/add.14993. Epub 2020 Mar 7. Addiction. 2020. PMID: 32003088
-
Marijuana and tobacco use and co-use among African Americans: results from the 2013, National Survey on Drug Use and Health.Addict Behav. 2015 Dec;51:18-23. doi: 10.1016/j.addbeh.2015.06.046. Epub 2015 Jul 10. Addict Behav. 2015. PMID: 26186376
-
Brief interventions for cannabis use in emerging adults: protocol for a systematic review, meta-analysis, and evidence map.Syst Rev. 2018 Jul 25;7(1):106. doi: 10.1186/s13643-018-0772-z. Syst Rev. 2018. PMID: 30045752 Free PMC article.
-
Differential item functioning analysis of the CUDIT and relations with alcohol and tobacco use among men across five ethnic groups: The HELIUS study.Psychol Addict Behav. 2019 Dec;33(8):697-709. doi: 10.1037/adb0000521. Epub 2019 Nov 7. Psychol Addict Behav. 2019. PMID: 31697091 Free PMC article.
Cited by
-
Cannabis and tobacco use and co-use: Trajectories and correlates from early adolescence to emerging adulthood.Drug Alcohol Depend. 2019 Nov 1;204:107499. doi: 10.1016/j.drugalcdep.2019.06.004. Epub 2019 Aug 24. Drug Alcohol Depend. 2019. PMID: 31479864 Free PMC article.
-
Rising trend of acute myocardial infarction among young cannabis users: A 10-year nationwide gender and race stratified analysis.Int J Cardiol Cardiovasc Risk Prev. 2022 Dec 29;16:200167. doi: 10.1016/j.ijcrp.2022.200167. eCollection 2023 Mar. Int J Cardiol Cardiovasc Risk Prev. 2022. PMID: 36874042 Free PMC article.
-
Who responds to a multi-component treatment for cannabis use disorder? Using multivariable and machine learning models to classify treatment responders and non-responders.Addiction. 2023 Oct;118(10):1965-1974. doi: 10.1111/add.16226. Epub 2023 Jun 4. Addiction. 2023. PMID: 37132085 Free PMC article. Clinical Trial.
-
Cultural race-related stress and cannabis use among incarcerated African American men.Psychol Addict Behav. 2021 May;35(3):320-325. doi: 10.1037/adb0000694. Epub 2021 Feb 8. Psychol Addict Behav. 2021. PMID: 33555899 Free PMC article.
-
Technology-based and digital interventions for intimate partner violence: A systematic review and meta-analysis.Campbell Syst Rev. 2022 Aug 27;18(3):e1271. doi: 10.1002/cl2.1271. eCollection 2022 Sep. Campbell Syst Rev. 2022. PMID: 36909881 Free PMC article. Review.
References
-
-
Ahluwalia JS, Harris KJ, Catley D, Okuyemi KS, & Mayo MS (2002). Sustained-release bupropion for smoking cessation in African Americans: A randomized controlled trial. Journal of the American Medical Association, 288, 468–474. 10.1001/jama.288.4.468
*
-
-
-
Ahluwalia JS, McNagny SE, & Clark WS (1998). Smoking cessation among inner-city African Americans using the nicotine transdermal patch. Journal of General Internal Medicine, 13, 1–8. 10.1046/j.1525-1497.1998.00001.x
*
-
-
-
Ahluwalia JS, Okuyemi K, Nollen N, Choi WS, Kaur H, Pulvers K, & Mayo MS (2006). The effects of nicotine gum and counseling among African American light smokers: A 2 ˣ 2 factorial design. Addiction, 101, 883–891. 10.1111/j.1360-0443.2006.01461.x
*
-
-
-
Ahluwalia JS, Richter KP, Mayo MS, & Resnicow K (1999). Quit for Life: A randomized trial of culturally sensitive materials for smoking cessation in African Americans. Journal of General Internal Medicine, 14(Suppl. 2), 6.
*
-
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources